Adoptive Immunotherapy of Tr1 Cells to Improve Outcome of Allo-HSCT Treatment for Pediatric AML |
Stanford University / Maria-Grazia Roncarolo, MD & Rosa Bachetta, MD |
Reach Grants |
2015 |
California |
Factors Affecting Parental Satisfaction, Anxiety and Comprehension of the Informed Consent in Pediatric Oncology Clinical Trials |
University of California, San Diego / Paula Aristizabal, MD |
Psychosocial Grants |
2015 |
California |
Preclinical Development of Atr Inhibitor VE-822, Delivered Systemically in Nanoparticles, for Medulloblastoma Therapy |
University of North Carolina / Timothy Gershon, MD, PhD |
Innovation Grants |
2015 |
North Carolina |
Circadian Rhythms, Fatigue and Bright Light Therapy in Adolescent Cancer Survivors |
University of Maryland, College Park / Valerie E. Rogers, PhD |
Nurse Researcher Grants |
2015 |
Maryland |
Integrative Genomic and Immunogenomic Analysis of Neuroblastoma |
University of California at Santa Cruz / David Haussler, PhD |
Innovation Grants |
2015 |
California |
Zebrafish Modeling of PAX3-FOXO1 Driven Rhabdomyosarcoma |
University of Texas Southwestern Medical Center / Genevieve Kendall, PhD |
Young Investigator Grants |
2015 |
Texas |
Space-Time Analysis of the California Birth Cohort: 30 Years of Childhood Cancer |
University of California Berkeley / Steve Selvin, PhD |
Epidemiology Grants |
2015 |
California |
Inside-Out Immunotherapy: Combating Neuroblastoma via Nanoparticle-Directed Reprogramming of the Tumor Microenvironment |
Vanderbilt University Medical Center / John Wilson, PhD |
'A' Award Grants |
2015 |
Tennessee |
Prospective Symptom Assessment in Children with Advanced Cancer |
University of Wisconsin - Madison / Kathleen Montgomery, PhD & Jennifer Madden, RN/MSN |
Nurse Researcher Grants |
2015 |
Wisconsin |
Identifying how Pre-existing Anti-Therapeutic Antibodies (PATA) are Associated with Better Outcome in a Clinical Trial of ADCC-inducing Anti-GD2 mAb |
University of Wisconsin - Madison / Paul Sondel, MD, PhD |
Innovation Grants |
2015 |
Wisconsin |